Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Solano

Showing results (41-50 of 273) with videos related to

Pageof 28
Sort By:
British Journal of Haematology|September 12, 2025
Pre-infusion cytomegalovirus T-cell immunity for predicting the risk of virus DNAemia in patients undergoing chimeric antigen receptor T-cell therapiesEliseo Albert, Rafael Hernani, Estela Giménez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 10, 2026
SARS-CoV-2 spike-directed T cells and anti-receptor-binding-domain antibodies in hematological patients receiving three mRNA COVID-19 vaccine dosesDiego Carretero, Estela Giménez, Ariadna Pérez, et al.
Journal of Medical Virology|July 5, 2023
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept studyCarlos Solano de la Asunción, Estela Giménez, Juan Carlos Hernández-Boluda, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 14, 2023
Cytomegalovirus DNAemia in haematological patients undergoing CD19-directed chimeric antigen receptor T-cell therapy: should it be systematically monitored?Carlos Solano de la Asunción, Rafael Hernani, Eliseo Albert, et al.
Leukemia & Lymphoma|April 6, 2011
An XRCC1 polymorphism is associated with the outcome of patients with lymphoma undergoing autologous stem cell transplantVicent M Guillem, Cristina Arbona, Juan Carlos Hernández-Boluda, et al.
Journal of the American Chemical Society|February 10, 2022
Counterintuitive Electrostatics upon Metal Ion Coordination to a Receptor with Two Homotopic Binding SitesVidar Aspelin, Anna Lidskog, Carlos Solano Arribas, et al.
Journal of Medical Virology|January 13, 2026
Cytomegalovirus IL-10 in Plasma as a Marker of Active Infection in Allogeneic Hematopoietic Transplant Recipients: An Exploratory StudyÁngela Sánchez-Simarro, Eliseo Albert, Estela Giménez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 16, 2023
Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advancesJose L Piñana, Ariadna Pérez, Pedro Chorão, et al.
Journal of Medical Virology|March 25, 2015
Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemiaEstela Giménez, Carlos Solano, Paula Amat, et al.
European Journal of Medicinal Chemistry|August 1, 2014
Towards the development of chromone-based MEK1/2 modulatorsItedale Namro Redwan, Christine Dyrager, Carlos Solano, et al.
Pageof 28

Showing results (41-50 of 273) with videos related to

Sort By:
Pageof 28
British Journal of Haematology|September 12, 2025
Pre-infusion cytomegalovirus T-cell immunity for predicting the risk of virus DNAemia in patients undergoing chimeric antigen receptor T-cell therapiesEliseo Albert, Rafael Hernani, Estela Giménez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 10, 2026
SARS-CoV-2 spike-directed T cells and anti-receptor-binding-domain antibodies in hematological patients receiving three mRNA COVID-19 vaccine dosesDiego Carretero, Estela Giménez, Ariadna Pérez, et al.
Journal of Medical Virology|July 5, 2023
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept studyCarlos Solano de la Asunción, Estela Giménez, Juan Carlos Hernández-Boluda, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 14, 2023
Cytomegalovirus DNAemia in haematological patients undergoing CD19-directed chimeric antigen receptor T-cell therapy: should it be systematically monitored?Carlos Solano de la Asunción, Rafael Hernani, Eliseo Albert, et al.
Leukemia & Lymphoma|April 6, 2011
An XRCC1 polymorphism is associated with the outcome of patients with lymphoma undergoing autologous stem cell transplantVicent M Guillem, Cristina Arbona, Juan Carlos Hernández-Boluda, et al.
Journal of the American Chemical Society|February 10, 2022
Counterintuitive Electrostatics upon Metal Ion Coordination to a Receptor with Two Homotopic Binding SitesVidar Aspelin, Anna Lidskog, Carlos Solano Arribas, et al.
Journal of Medical Virology|January 13, 2026
Cytomegalovirus IL-10 in Plasma as a Marker of Active Infection in Allogeneic Hematopoietic Transplant Recipients: An Exploratory StudyÁngela Sánchez-Simarro, Eliseo Albert, Estela Giménez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 16, 2023
Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advancesJose L Piñana, Ariadna Pérez, Pedro Chorão, et al.
Journal of Medical Virology|March 25, 2015
Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemiaEstela Giménez, Carlos Solano, Paula Amat, et al.
European Journal of Medicinal Chemistry|August 1, 2014
Towards the development of chromone-based MEK1/2 modulatorsItedale Namro Redwan, Christine Dyrager, Carlos Solano, et al.
Pageof 28